TLC-2716 was well tolerated and improved atherogenic lipid parameters in healthy individuals Given the favorable efficacy and toxicological profile in preclinical species, a randomized, placebo-controlled phase 1 clinical trial of TLC-2716 was conducted in humans (ClinicalTrials.govNCT05483998, from 27 July 2022 to 18 June 2023
However, another study concluded that the activation of Bax by flavokavain A, in an invasive bladder cancer cell line T24, might be p53 independent [106]
Photo by Innerbody Research One thing a lot of supplement users have in common is the desire to live longer and be healthier
Embark on your journey to optimal living now
Forum threads show users complaining they cannot find a single report of someone curing gastritis or ulcers with oral BPC-157 despite the peptide being studied for exactly that purpose
However, the high cost of protein testing technology and its broad dynamic range present unique challenges